For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) within Human MTA2 aa 650 to the C-terminus. The exact sequence is proprietary.
Database link: O94776
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents
This product is a recombinant rabbit monoclonal antibody.
Our Abpromise guarantee covers the use of ab171073 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|ICC/IF||1/250 - 1/500.|
|Flow Cyt||1/100 - 1/500.
ab172730 - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.
|IHC-P||1/50 - 1/100.
Antigen retrieval is recommended
|WB||1/1000 - 1/5000. Predicted molecular weight: 75 kDa.|
Immunohistochemical analysis of paraffin-embedded Human colonic carcinoma tissue labeling MTA2 with ab171073 at 1/50 dilution.
Immunohistochemical analysis of paraffin-embedded Human kidney tissue labeling MTA2 with ab171073 at 1/50 dilution.
Immunofluorescent staining of HeLa cells labeling MTA2 with ab171073 at 1/250 dilution.
Flow cytometric analysis of permeabilized Hela cells labeling MTA2 with ab171073 at 1/100 dilution (red) or a rabbit IgG negative (green).
ab171073 has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"